146 related articles for article (PubMed ID: 14616442)
1. The clinical implications of the prostate cancer prevention trial.
Marberger M; Adolfsson J; Borkowski A; Fitzpatrick J; Kirk D; Prezioso D; Rabaça C; Solsona E; Teillac P
BJU Int; 2003 Nov; 92(7):667-71. PubMed ID: 14616442
[No Abstract] [Full Text] [Related]
2. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
Walsh PC
J Urol; 1999 Jan; 161(1):350-1. PubMed ID: 10037436
[No Abstract] [Full Text] [Related]
3. Prevention of prostate cancer with finasteride.
Burke HB
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
[No Abstract] [Full Text] [Related]
4. The evolution of the PCPT from clinical to molecular analyses.
Hoque A
Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
[No Abstract] [Full Text] [Related]
5. High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact?
Andriole GL; Humphrey PA; Serfling RJ; Grubb RL
J Natl Cancer Inst; 2007 Sep; 99(18):1355-6. PubMed ID: 17848666
[No Abstract] [Full Text] [Related]
6. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
Etzioni RD; Howlader N; Shaw PA; Ankerst DP; Penson DF; Goodman PJ; Thompson IM
J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
[TBL] [Abstract][Full Text] [Related]
7. Prevention of prostate cancer with finasteride.
Ross RK; Skinner E; Cote RJ
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
[No Abstract] [Full Text] [Related]
8. Guideline supports long-term use of medication to lower prostate cancer risk.
Mitka M
JAMA; 2009 May; 301(17):1753-4. PubMed ID: 19417182
[No Abstract] [Full Text] [Related]
9. Prostate cancer prevention and finasteride.
D'Amico AV; Barry MJ
J Urol; 2006 Nov; 176(5):2010-2; discussion 2012-3. PubMed ID: 17070238
[TBL] [Abstract][Full Text] [Related]
10. High-grade prostate cancer and the prostate cancer prevention trial.
Logothetis CJ; Schellhammer PF
Cancer Prev Res (Phila); 2008 Aug; 1(3):151-2. PubMed ID: 19138948
[No Abstract] [Full Text] [Related]
11. New finasteride trial results aim to curb controversy.
Bankhead C
J Natl Cancer Inst; 2006 Aug; 98(16):1104-5. PubMed ID: 16912260
[No Abstract] [Full Text] [Related]
12. [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].
Schmitz-Dräger BJ; Fischer C; Bismarck E; Dörsam HJ; Lümmen G
Urologe A; 2007 Oct; 46(10):1364, 1366-8, 1370. PubMed ID: 17874228
[TBL] [Abstract][Full Text] [Related]
13. Finasteride for chemoprevention of prostate cancer: why has it not been embraced?
de Vere White RW
J Clin Oncol; 2007 Jul; 25(21):2999-3000. PubMed ID: 17634478
[No Abstract] [Full Text] [Related]
14. Prostate cancer prevention trial yields positive results, but with a few cautions.
Reynolds T
J Natl Cancer Inst; 2003 Jul; 95(14):1030-1. PubMed ID: 12865442
[No Abstract] [Full Text] [Related]
15. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
Lotan Y; Cadeddu JA; Lee JJ; Roehrborn CG; Lippman SM
J Clin Oncol; 2005 Mar; 23(9):1911-20. PubMed ID: 15774783
[TBL] [Abstract][Full Text] [Related]
16. Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.
Beer TM
Health News; 2003 Aug; 9(8):1-2. PubMed ID: 12971313
[No Abstract] [Full Text] [Related]
17. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
Hausmann R; Thalmann G; Reich O; Steif CG
Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
[No Abstract] [Full Text] [Related]
18. High-grade prostate cancer and finasteride.
Lebdai S; Bigot P; Azzouzi AR
BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
[TBL] [Abstract][Full Text] [Related]
19. [The pathologist's perspective on the PCPT trial].
Molinié V; Allory Y
Prog Urol; 2008 Apr; 18 Suppl 3():S47-52. PubMed ID: 18455084
[TBL] [Abstract][Full Text] [Related]
20. Five-alpha-reductase Inhibitors for prostate cancer prevention.
Wilt TJ; MacDonald R; Hagerty K; Schellhammer P; Kramer BS
Cochrane Database Syst Rev; 2008 Apr; (2):CD007091. PubMed ID: 18425978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
